Abstract
Key Points Opportunities exist for clinical decision support (CDS) to help transplant nephrologists counsel living donors receiving apolipoprotein L1 (APOL1) genetic test results.CDS for APOL1 genetic test results should provide access to patient education materials and reminders at follow-up appointments.Optimal APOL1 CDS would notify providers when results are available, provide information on follow-up appointments, and provide access to patient education materials. Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2023_12_01_KID0000000000000265.mp3
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
